Global Nuclear Medicine Market History and New Update with Current Trend History and New Update with Current Trend 2017-2020
 |
| Nuclear Medicine |
Albany, New York, Apr 21, 2017
"Global
Nuclear Medicine Market 2017-2020"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
– About
Nuclear Medicine
Nuclear medicine is a specialty branch of medical imaging that involves the use of modalities such as SPECT and PET scans. These technologies help detect and evaluate various disorders in the areas of oncology, cardiology, and neurology. Modalities for nuclear medicine involve the use of a minimal amount of radioisotopes that are either injected, swallowed, or inhaled by an individual. These radioisotopes reach the specific organ targeted by the pharmaceutical compound and emit radiations that can be detected using a scanner or a detector.
Technavios analysts forecast the global nuclear medicine market to grow at a CAGR of 8.34% during the period 2017-2020.
Nuclear medicine is a specialty branch of medical imaging that involves the use of modalities such as SPECT and PET scans. These technologies help detect and evaluate various disorders in the areas of oncology, cardiology, and neurology. Modalities for nuclear medicine involve the use of a minimal amount of radioisotopes that are either injected, swallowed, or inhaled by an individual. These radioisotopes reach the specific organ targeted by the pharmaceutical compound and emit radiations that can be detected using a scanner or a detector.
Technavios analysts forecast the global nuclear medicine market to grow at a CAGR of 8.34% during the period 2017-2020.
–
Covered in this report
The report covers the present scenario and the growth prospects of the global nuclear medicine market for 2017-2020. To calculate the market size, the report considers the use revenue generated from the sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and therapeutic purposes.
The report covers the present scenario and the growth prospects of the global nuclear medicine market for 2017-2020. To calculate the market size, the report considers the use revenue generated from the sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and therapeutic purposes.
–
The market is divided into the following segments based on
geography:
Americas
EMEA
APAC
Technavio's report, Global Nuclear Medicine Market 2017-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
– Key vendors
Cardinal Health
Digirad
GE Healthcare
Lantheus Medical Imaging
Philips Healthcare
Americas
EMEA
APAC
Technavio's report, Global Nuclear Medicine Market 2017-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
– Key vendors
Cardinal Health
Digirad
GE Healthcare
Lantheus Medical Imaging
Philips Healthcare
–
Other prominent vendors
ABT Molecular Imaging
Advanced Accelerator Applications
AGFA Healthcare
Algeta
Astellas Pharma
Bayer
Bracco Imaging
Brain Biosciences
Capintec
CMR Naviscan
Cubresa
Eczacibasi-Monrol Nuclear Products
FUJIFILM Holdings
IBA Molecular Imaging
ISOLOGIC Innovative Radiopharmaceuticals
Jubilant DraxImage
Mallinckrodt
Mediso Medical Imaging System
Mirada Medical
Navidea Biopharmaceuticals
Nordion
Piramal Imaging
Positron Pharmaceutical Company
RadioMedix
SHINE Medical Technologies
Sophie Biosciences
Toshiba Medical Systems
Triad Isotopes
Voxel
Market driver
Growing demand for radiopharmaceuticals
For a full, detailed list, view our report
– Market challenge
High cost of nuclear medicine and time constraints owing to its short half-life
For a full, detailed list, view our report
– Market trend
Partnerships for development of nuclear medicine
For a full, detailed list, view our report
– Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
ABT Molecular Imaging
Advanced Accelerator Applications
AGFA Healthcare
Algeta
Astellas Pharma
Bayer
Bracco Imaging
Brain Biosciences
Capintec
CMR Naviscan
Cubresa
Eczacibasi-Monrol Nuclear Products
FUJIFILM Holdings
IBA Molecular Imaging
ISOLOGIC Innovative Radiopharmaceuticals
Jubilant DraxImage
Mallinckrodt
Mediso Medical Imaging System
Mirada Medical
Navidea Biopharmaceuticals
Nordion
Piramal Imaging
Positron Pharmaceutical Company
RadioMedix
SHINE Medical Technologies
Sophie Biosciences
Toshiba Medical Systems
Triad Isotopes
Voxel
Market driver
Growing demand for radiopharmaceuticals
For a full, detailed list, view our report
– Market challenge
High cost of nuclear medicine and time constraints owing to its short half-life
For a full, detailed list, view our report
– Market trend
Partnerships for development of nuclear medicine
For a full, detailed list, view our report
– Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Comments
Post a Comment